PUREVAX
® FELINE 4
Merial
Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine
Modified Live Virus and Chlamydia
DESCRIPTION: PUREVAX® Feline 4 contains a lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci, each propagated in a stable cell line, plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
INDICATIONS: PUREVAX® Feline 4 is recommended for the vaccination of healthy cats 6 weeks of age and older for prevention of disease due to feline rhinotracheitis, calici, and panleukopenia viruses and as an aid in the reduction of disease due to Chlamydia psittaci.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy cats. For primary vaccination, revaccinate with a second 1 mL dose 3 to 4 weeks later. Cats younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 3 to 4 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn the container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.
Sold to veterinarians only.
For Veterinary Use Only.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
1-888-Merial-1 (1-888-637-4251)
PUREVAX is a registered trademark of MERIAL.
|
Contains
|
|
Prod. No.
|
|
|
25 Doses
|
25 x 1 Dose, Lyophilized
25 x 1 mL, Sterile Water
|
2144-25
|
RM504R4
|
NAC No.: 11110542